Efficacy of tiotropium/olodaterol compared with tiotropium in patients naïve to LAMA, LABA and ICS, and patients receiving only LAMA at baseline: pooled analysis of four clinical trials

27 Jun 2020
pdf
Presentation: Efficacy of tiotropium/olodaterol vs tiotropium in treatment-naïve patients and patients receiving only LAMA
874.28 KB
pdf
Abstract: Efficacy of tiotropium/olodaterol vs tiotropium in treatment-naïve patients and patients receiving only LAMA
251.78 KB

Resource information

Respiratory topics
  • Treatment - drug
Type of resource
Abstract
Conference
2020 Virtual Conferences
Author(s)
Roland Buhl1, Alberto de la Hoz2, Florian Voß3, Dave Singh4, Gary T. Ferguson5 1Johannes Gutenberg University Hospital Mainz, Mainz, Germany, 2Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany, 3Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany, 4Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester, UK, 5Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA